Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Immatics biotechnologies

Explore full profile

Combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets

Tübingen, GermanyFounded 2000Biotech & Life Sciences
Valuation $677M Market cap · Aug/2026
Revenue $47M Latest reported FY

At a glance

Status
Listed
Founded
2000
Headquarters
Tübingen, Germany
Listing
Public via SPAC 2020
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • EMBL Ventures
  • 3i Group
  • Wellington Partners
  • L-Bank
  • Vinci Capital
  • Grazia Equity

Series B and later11 investors entered at this stage

  • Bristol-Myers Squibb
  • DH Capital
  • MIG Capital
  • b2venture
  • KfW
  • dievini Hopp Biotech holding
  • Celgene
  • Swisscom Ventures
  • AT Impf GmbH
  • Amgen
  • Dezima Pharma

Talent

Book a demo to see the people
Employees mapped 649 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 14 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Immatics biotechnologies employees who went on to found companies, sorted by Dealroom signal score.

KvantumEst. 2012
Harpreet SinghUnited States
Signal score96
IOmx Therapeutics AGEst. 2016
Sebastian Meier-EwertGermany
Signal score68
Affinia TherapeuticsEst. 2019
Rob Johnson.United States
Signal score62
Domus DiagnosticsEst. 2021
HSHarald Casebourne StockUnited States
Signal score48
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇩🇪 Germany55.9%
🇺🇸 United States42.8%
🇨🇭 Switzerland0.4%
🇳🇱 Netherlands0.2%
🇮🇳 India0.2%
Top 5 of 7 shown
Web traffic by country
26K monthly visits
across markets
🇺🇸 United States81.5%
🇬🇧 United Kingdom6.5%
🇩🇪 Germany4.6%
🇮🇳 India4.2%
🇨🇦 Canada3.1%
Top 5 markets shown

Patents

Estimated portfolio value
$272M

204 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Immatics biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Immatics biotechnologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles